AeroSafe Blog New vaccines emerge, renewing cold chain awareness and market growth

Earlier this year the FDA approved the first two vaccines for RSV aimed at older adults. This new preventive mechanism, along with updated COVID and influenza vaccines, offer a good percentage of the population enhanced protection against the "triple-demic" of serious respiratory illness. As vaccine vials make their way to hospitals, clinics, and pharmacies for administration to millions of individuals their effectiveness is preserved by, among other protections, temperature-controlled packaging.